Cancer Drug
-
{
- All
- News
- Videos
-
Smart Cancer Drug Can Shrink Tumours By 30% In Early Trial
In an early-stage (Phase 1) trial of 83 patients, the drug shrank tumours in 26 people. For 15 of those patients, their tumours shrank by at least 30%.
-
Jill Biden Says She's Sorry She Didn't Talk More About Son Hunter's Drug Addiction
Jill Biden says she's sorry she didn't talk more about her son Hunter's drug addiction during her time in the White House, explaining that she now realizes that being open about his substance abuse and his recovery can offer hope to others in the same situation.
-
Major Breakthroughs In Pancreatic Cancer Treatment And Weight Loss Medication Benefits Discussed At ASCO Summit
Cancer researchers highlighted several treatment breakthroughs during their annual summit in Chicago that concluded Tuesday, including preliminary but encouraging data on potential...
-
New Drug-Vaccine Combo Cuts Melanoma Recurrence Risk By Nearly 50%, Finds Study
Researchers have found that a combination of a personalised cancer vaccine and an immunotherapy drug can significantly lower the chances of the disease returning after surgery. This treatment has shown benefits, even after five years of follow-up.
-
Pancreatic Cancer Breakthrough: New Daily Pill Doubles Survival Time For Advanced Patients
A new once-daily targeted therapy, daraxonrasib, has nearly doubled survival in patients with advanced pancreatic cancer in a landmark Phase 3 trial. Experts are calling it one of the most significant breakthroughs against one of the world's deadliest cancers in decades.
-
Experimental Pill Promises New Hope For Deadly Pancreatic Cancer
The drug is called daraxonrasib and it blocks a mutated protein that fuels tumor growth in more than 90% of pancreatic cancer cases — a target that had eluded treatment for decades.
-
UK Wellness Coach Dies After Taking Drug Made Of Toxic Frog Secretion During Cleansing Ritual
Trend's death has drawn widespread attention because it came only months after he had reportedly overcome Burkitt lymphoma, a rare and aggressive form of blood cancer.
-
7-Minute Cancer Shot Costing Rs 3.7 Lakh Per Dose Launched In India
The new injection uses a drug called atezolizumab, which works by blocking a protein called PD-L1. Cancer cells use this protein to hide from the immune system. Once the protein is blocked, the body's immune cells can identify and attack cancer cells
-
Eli Lilly Launches Alzheimer's Drug Lormalzi Priced At Rs 91,688 Per Vial In India
Eli Lilly has launched Lormalzi (donanemab) in India for early Alzheimer's disease at Rs91,688 per vial. The once-monthly therapy targets amyloid plaques and may help slow cognitive decline in eligible patients with mild symptoms.
-
Rs 10 Crore Fake Medicine Racket Busted In Delhi, 4 Arrested
The gang specialized in faking high-stakes treatments for cancer, liver disease, and other critical illnesses, putting countless lives at risk across the country.
-
IIT Gandhinagar Develops Hydrogel-Based Technology To Simplify Colon Tumour Surgery
Gandhinagar, April 19 (IANS) In a landmark achievement, the IIT Gandhinagar has developed a hydrogel-based technology with potential of spurring further innovations -- thereby resulting in "simplification" of surgery for colon-related tumours.
-
Which Cancers Does Keytruda Work On? Apollo Oncologists Explain Effectiveness
The Drug Controller General of India (DCGI) has approved Keytruda for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
-
High Cost, Limited Access: How Counterfeit Keytruda Market Puts Cancer Patients At Risk
Keytruda, developed by Merck & Co., belongs to a class of drugs known as immune checkpoint inhibitors, which help the immune system identify and attack cancer cells.
-
Oncologists Explain Why They Prescribe Keytruda To Cancer Patients, When And How It Works
Keytruda is approved by the Drug Controller General of India (DCGI) for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
-
What Is Keytruda And Why Is Everyone Talking About It In India's Cancer Fight?
In India, Keytruda is approved by the Drug Controller General of India (DCGI) for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
-
Smart Cancer Drug Can Shrink Tumours By 30% In Early Trial
In an early-stage (Phase 1) trial of 83 patients, the drug shrank tumours in 26 people. For 15 of those patients, their tumours shrank by at least 30%.
-
Jill Biden Says She's Sorry She Didn't Talk More About Son Hunter's Drug Addiction
Jill Biden says she's sorry she didn't talk more about her son Hunter's drug addiction during her time in the White House, explaining that she now realizes that being open about his substance abuse and his recovery can offer hope to others in the same situation.
-
Major Breakthroughs In Pancreatic Cancer Treatment And Weight Loss Medication Benefits Discussed At ASCO Summit
Cancer researchers highlighted several treatment breakthroughs during their annual summit in Chicago that concluded Tuesday, including preliminary but encouraging data on potential...
-
New Drug-Vaccine Combo Cuts Melanoma Recurrence Risk By Nearly 50%, Finds Study
Researchers have found that a combination of a personalised cancer vaccine and an immunotherapy drug can significantly lower the chances of the disease returning after surgery. This treatment has shown benefits, even after five years of follow-up.
-
Pancreatic Cancer Breakthrough: New Daily Pill Doubles Survival Time For Advanced Patients
A new once-daily targeted therapy, daraxonrasib, has nearly doubled survival in patients with advanced pancreatic cancer in a landmark Phase 3 trial. Experts are calling it one of the most significant breakthroughs against one of the world's deadliest cancers in decades.
-
Experimental Pill Promises New Hope For Deadly Pancreatic Cancer
The drug is called daraxonrasib and it blocks a mutated protein that fuels tumor growth in more than 90% of pancreatic cancer cases — a target that had eluded treatment for decades.
-
UK Wellness Coach Dies After Taking Drug Made Of Toxic Frog Secretion During Cleansing Ritual
Trend's death has drawn widespread attention because it came only months after he had reportedly overcome Burkitt lymphoma, a rare and aggressive form of blood cancer.
-
7-Minute Cancer Shot Costing Rs 3.7 Lakh Per Dose Launched In India
The new injection uses a drug called atezolizumab, which works by blocking a protein called PD-L1. Cancer cells use this protein to hide from the immune system. Once the protein is blocked, the body's immune cells can identify and attack cancer cells
-
Eli Lilly Launches Alzheimer's Drug Lormalzi Priced At Rs 91,688 Per Vial In India
Eli Lilly has launched Lormalzi (donanemab) in India for early Alzheimer's disease at Rs91,688 per vial. The once-monthly therapy targets amyloid plaques and may help slow cognitive decline in eligible patients with mild symptoms.
-
Rs 10 Crore Fake Medicine Racket Busted In Delhi, 4 Arrested
The gang specialized in faking high-stakes treatments for cancer, liver disease, and other critical illnesses, putting countless lives at risk across the country.
-
IIT Gandhinagar Develops Hydrogel-Based Technology To Simplify Colon Tumour Surgery
Gandhinagar, April 19 (IANS) In a landmark achievement, the IIT Gandhinagar has developed a hydrogel-based technology with potential of spurring further innovations -- thereby resulting in "simplification" of surgery for colon-related tumours.
-
Which Cancers Does Keytruda Work On? Apollo Oncologists Explain Effectiveness
The Drug Controller General of India (DCGI) has approved Keytruda for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
-
High Cost, Limited Access: How Counterfeit Keytruda Market Puts Cancer Patients At Risk
Keytruda, developed by Merck & Co., belongs to a class of drugs known as immune checkpoint inhibitors, which help the immune system identify and attack cancer cells.
-
Oncologists Explain Why They Prescribe Keytruda To Cancer Patients, When And How It Works
Keytruda is approved by the Drug Controller General of India (DCGI) for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
-
What Is Keytruda And Why Is Everyone Talking About It In India's Cancer Fight?
In India, Keytruda is approved by the Drug Controller General of India (DCGI) for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
